Sorafenib plus transarterial chemoembolization for unresectable hepatocellular carcinoma: Acknowledgments.

ABSTRACT:

SUBMITTER: Tsilimigras DI 

PROVIDER: S-EPMC7791245 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature